Epigenetic regulation of the glucose transporter gene Slc2a1 by β-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice

Genes to Cells

Volumn 22, Issue 1, 2017, Pages 71-83

  Tanegashima, Kosuke ^a   Sato Miyata, Yukiko ^b   Funakoshi, Masabumi ^b   Nishito, Yasumasa ^a   Aigaki, Toshiro ^b   Hara, Takahiko ^a,c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; GLUCOSE TRANSPORTER 1; HISTONE DEACETYLASE 2; KETONE BODY; GLUCOSE; HDAC2 PROTEIN, MOUSE; SLC2A1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE INTAKE; HDAC2 GENE; HISTONE ACETYLATION; HISTONE MODIFICATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SLC2A1 GENE; TANDEM MASS SPECTROMETRY; UPREGULATION; ACETYLATION; ANIMAL; BIOSYNTHESIS; BRAIN; CRISPR CAS SYSTEM; DIET RESTRICTION; ENDOTHELIUM CELL; GENETIC EPIGENESIS; GENETICS; HISTONE CODE; METABOLISM; METABOLOME; NERVE CELL; PATHOLOGY;

3-HYDROXYBUTYRIC ACID; ACETYLATION; ANIMALS; BRAIN; CRISPR-CAS SYSTEMS; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; FASTING; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HISTONE CODE; HISTONE DEACETYLASE 2; KETONE BODIES; METABOLOME; MICE; NEURONS;

EID: 85006771072     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12456     Document Type: Article

References (35)

1. Benjamini, Y. & Hochberg, Y. (1995) Controling the false discovery rate: a pratical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 298–300.
2. Berg, J.M., Tymoczko, J.L. & Stryer, L. (2002) Biochemistry, 5th edition, New York, NY: W. H. Freeman Publishers.
3. Brockmann, K. (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev. 31, 545–552.
4. Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F. & Maity, A. (2001) Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J. Biol. Chem. 276, 9519–9525.
5. Ge, X., Chen, C., Hui, X., Wang, Y., Lam, K.S. & Xu, A. (2011) Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes. J. Biol. Chem. 286, 34533–34541.
6. Gottlicher, M., Minucci, S., Zhu, P., Kramer, O.H., Schimpf, A., Giavara, S., Sleeman, J.P., Lo Coco, F., Nervi, C., Pelicci, P.G. & Heinzel, T. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969–6978.
7. Graff, J., Rei, D., Guan, J.S. et al. (2012) An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222–226.
8. Guo, X., Geng, M. & Du, G. (2005) Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem. Genet. 43, 175–187.
9. Hahn, T.M., Breininger, J.F., Baskin, D.G. & Schwartz, M.W. (1998) Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience 1, 271–272.
10. Hakvoort, T.B., Moerland, P.D., Frijters, R., Sokolovic, A., Labruyere, W.T., Vermeulen, J.L., Loren, Ver., van Themaat, E., Breit, T.M., Wittink, F.R., van Kampen, A.H., Verhoeven, A.J., Lamers, W.H. & Sokolovic, M. (2011) Interorgan coordination of the murine adaptive response to fasting. J. Biol. Chem. 286, 16332–16343.
11. Hasselbalch, S.G., Knudsen, G.M., Jakobsen, J., Hageman, L.P., Holm, S. & Paulson, O.B. (1995) Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am. J. Physiol. 268, E1161–E1166.
12. Hegardt, F.G. (1999) Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. Biochem J. 338(Pt 3), 569–582.
13. Horwood, N. & Davies, D.C. (1994) Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch. 425, 69–72.
14. Huang, Y., Lei, L., Liu, D., Jovin, I., Russell, R., Johnson, R.S., Di Lorenzo, A. & Giordano, F.J. (2012) Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alpha-dependent function. Proc. Natl Acad. Sci. USA 109, 17478–17483.
15. Huber, K., Doyon, G., Plaks, J., Fyne, E., Mellors, J.W. & Sluis-Cremer, N. (2011) Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells. J. Biol. Chem. 286, 22211–22218.
16. Kalaria, R.N. & Harik, S.I. (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 53, 1083–1088.
17. Leino, R.L., Gerhart, D.Z., Duelli, R., Enerson, B.E. & Drewes, L.R. (2001) Diet-induced ketosis increases monocarboxylate transporter (MCT1) levels in rat brain. Neurochem. Int. 38, 519–527.
18. Maher, F., Vannucci, S.J. & Simpson, I.A. (1993) Glucose transporter isoforms in brain: absence of GLUT3 from the blood-brain barrier. J. Cereb. Blood Flow Metab. 13, 342–345.
19. Mooradian, A.D., Chung, H.C. & Shah, G.N. (1997) GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol. Aging 18, 469–474.
20. Navone, S.E., Marfia, G., Invernici, G., Cristini, S., Nava, S., Balbi, S., Sangiorgi, S., Ciusani, E., Bosutti, A., Alessandri, G., Slevin, M. & Parati, E.A. (2013) Isolation and expansion of human and mouse brain microvascular endothelial cells. Nat. Protoc. 8, 1680–1693.
21. Paoli, A., Bianco, A., Damiani, E. & Bosco, G. (2014) Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res. Int. 2014, 474296.
22. Pardridge, W.M., Boado, R.J. & Farrell, C.R. (1990) Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J. Biol. Chem. 265, 18035–18040.
23. Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A. & Klein, P.S. (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734–36741.
24. Protas, H.D., Chen, K., Langbaum, J.B., Fleisher, A.S., Alexander, G.E., Lee, W., Bandy, D., de Leon, M.J., Mosconi, L., Buckley, S., Truran-Sacrey, D., Schuff, N., Weiner, M.W., Caselli, R.J. & Reiman, E.M. (2013) Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 70, 320–325.
25. Puchowicz, M.A., Xu, K., Sun, X., Ivy, A., Emancipator, D. & LaManna, J.C. (2007) Diet-induced ketosis increases capillary density without altered blood flow in rat brain. Am. J. Physiol. Endocrinol. Metab. 292, E1607–E1615.
26. Sato-Miyata, Y., Muramatsu, K., Funakoshi, M., Tsuda, M. & Aigaki, T. (2014) Overexpression of dilp2 causes nutrient-dependent semi-lethality in Drosophila. Front. Physiol. 5, 147.
27. Scheinberg, P. (1965) Observations on cerebral carbohydrate metabolism in man. Ann. Intern. Med. 62, 367–371.
28. Schreiber, R.A. & Yeh, Y.Y. (1984) Temporal changes in plasma levels and metabolism of ketone bodies by liver and brain after ethanol and/or starvation in C57BL/6J mice. Drug Alcohol Depend. 13, 151–160.
29. Seidner, G., Alvarez, M.G., Yeh, J.I., O'Driscoll, K.R., Klepper, J., Stump, T.S., Wang, D., Spinner, N.B., Birnbaum, M.J. & De Vivo, D.C. (1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat. Genet. 18, 188–191.
30. Shimazu, T., Hirschey, M.D., Newman, J. et al. (2013) Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211–214.
31. Wang, D., Pascual, J.M., Yang, H., Engelstad, K., Jhung, S., Sun, R.P. & De Vivo, D.C. (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann. Neurol. 57, 111–118.
32. Winkler, E.A., Nishida, Y., Sagare, A.P. et al. (2015) GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci. 18, 521–530.
33. Xia, J., Sinelnikov, I.V., Han, B. & Wishart, D.S. (2015) MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res. 43, W251–W257.
34. Xie, Z., Zhang, D., Chung, D. et al. (2016) Metabolic regulation of gene expression by histone lysine beta-hydroxybutyrylation. Mol. Cell 62, 194–206.
35. Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N.S., Cai, W., Yang, G., Bronson, R., Crowley, D.G., Zhang, F., Anderson, D.G., Sharp, P.A. & Jacks, T. (2014) CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 514, 380–384.